<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04312529</url>
  </required_header>
  <id_info>
    <org_study_id>1996</org_study_id>
    <nct_id>NCT04312529</nct_id>
  </id_info>
  <brief_title>Analysis of Shoulder Muscle Activity During Isokinetic Evaluation of Rotators</brief_title>
  <official_title>Analysis of Shoulder Muscle Activity During Isokinetic Evaluation of Rotators</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Liege</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Liege</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to assess the impact of different positions of the&#xD;
      glenohumeral joint on the maximum muscle contraction of different shoulder muscles. The&#xD;
      muscles do not contract with the same intensity depending on the position of the arm in&#xD;
      relation to the trunk. With the determination of this optimal position to activate the&#xD;
      shoulder muscles as much as possible, we will be able to strengthen the patients during their&#xD;
      revalidation.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">November 1, 2020</start_date>
  <completion_date type="Anticipated">September 2021</completion_date>
  <primary_completion_date type="Actual">December 24, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>strength test</measure>
    <time_frame>Day 1.</time_frame>
    <description>The strength will be assess with a isokinetic device. It will allow to calculate the maximum force of the subject at the level of the rotators of the shoulder. This is a dorsal decubitus test. The subject's arm will be positioned during one session in 45° of abduction and the other session in 90° of shoulder abduction.&#xD;
In this position, the subject will perform tests at different speeds (60°/s concentric, 240°/s concentric and 60°/s eccentric). This will calculate the maximum force.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Electrical activity of the muscles</measure>
    <time_frame>Day 1.</time_frame>
    <description>The electromyography will allow to calculate the electrical activity of the muscles during the two isokinetics and thus to determine which active position the most the muscles of the shoulder. This measurement is achieved by the installation of surface electrodes</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Weight</measure>
    <time_frame>Day 1</time_frame>
    <description>We will ask the weight of the subject to calculate his relative strength</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Muscle Activation</condition>
  <condition>Electromyography</condition>
  <condition>Muscle Strength</condition>
  <condition>Shoulder</condition>
  <arm_group>
    <arm_group_label>Overhead athletes</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Isokinetic test + EMG</intervention_name>
    <description>Isokinetic test:The isokinetic device is used to evaluate the strength of a subject. The test will be performed in two positions. This will determine the best position to activate shoulder muscles EMG (electromyography):it's a device that measures the electrical activity of muscles. This will allow us to record the maximum activity of the shoulder muscles during force tests.</description>
    <arm_group_label>Overhead athletes</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male subjects aged 18-35.&#xD;
&#xD;
          -  Playing a sport using the upper limb (handball, volleyball, swimming, tennis) at least&#xD;
             6h/week&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pain in the shoulder&#xD;
&#xD;
          -  Shoulder pathologies such as gleno-humeral dislocation, tendinopathy, sub-acromial&#xD;
             conflict, etc.&#xD;
&#xD;
          -  History of shoulder surgery (prosthesis, stabilizing surgery, etc.)&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Université de Liège</name>
      <address>
        <city>Liège</city>
        <zip>4000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>March 11, 2020</study_first_submitted>
  <study_first_submitted_qc>March 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 18, 2020</study_first_posted>
  <last_update_submitted>February 2, 2021</last_update_submitted>
  <last_update_submitted_qc>February 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Liege</investigator_affiliation>
    <investigator_full_name>Gofflot Amandine</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

